Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 2008. Start Trial.
Date Value
October 13, 2026 1.59
October 12, 2026 1.75
October 09, 2026 1.91
October 08, 2026 1.89
October 07, 2026 2.24
October 06, 2026 2.27
October 05, 2026 2.24
October 02, 2026 2.14
October 01, 2026 2.27
September 30, 2026 2.33
September 29, 2026 2.33
September 28, 2026 2.31
September 25, 2026 2.55
September 24, 2026 2.51
September 23, 2026 2.60
September 22, 2026 2.55
September 21, 2026 2.71
September 18, 2026 2.69
September 17, 2026 2.655
September 16, 2026 2.55
September 15, 2026 2.64
September 14, 2026 2.70
September 11, 2026 2.67
September 10, 2026 2.76
September 09, 2026 2.74
Date Value
September 08, 2026 2.803
September 04, 2026 2.96
September 03, 2026 2.874
September 02, 2026 4.034
September 01, 2026 3.965
August 31, 2026 4.048
August 28, 2026 3.982
August 27, 2026 4.12
August 26, 2026 4.338
August 25, 2026 4.45
August 24, 2026 4.264
August 21, 2026 4.306
August 20, 2026 4.412
August 19, 2026 4.266
August 18, 2026 4.26
August 17, 2026 4.40
August 14, 2026 4.518
August 13, 2026 4.404
August 12, 2026 4.246
August 11, 2026 4.20
August 10, 2026 4.02
August 07, 2026 4.08
August 06, 2026 4.168
August 05, 2026 4.20
August 04, 2026 4.20

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Myriad Genetics, Inc. 4.08
CareDx, Inc. 65.43
Natera, Inc. 395.66
Exagen, Inc. 8.48
Sera Prognostics, Inc. 2.04